Value stocks in the U.S. were down Friday afternoon, lagging growth equities as the stock market broadly rebounded. The ...

The Nasdaq Composite is attempting to climb its way back into positive territory for the week, as dip buyers returned after ...

The average checking account interest rate is 1.75 times higher than it was in 2022, according to October data from WalletHub ...

Small-caps stocks in the U.S., as measured by the Russell 2000 index, were recovering on Friday afternoon but still heading ...

HOBOKEN, N.J., Nov. 14, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today released ...

Merck & Co. is buying the developer of an experimental antiviral drug designed to prevent the flu, as the drugmaker aims to ...

GI Partners, a leading private alternatives investment firm with deep experience investing in data centers, and Legacy Investing, LLC, a leading data center developer and operator, today announced the ...

The U.S. stock market closed mostly lower Friday, with the S&P 500 giving up its gains shortly before the closing bell. The Dow Jones Industrial Average fell 0.7%, according to preliminary data from ...

America's Top Financial Advisory Firms award received in 2026 were granted by Newsweek, with assistance from Plant-A Insights Group. McAdam LLC did not apply for or pay for the award. The ranking of ...

The presale performance of MUTM has been one of the most impressive in 2025. Launched in early 2025 with a starting price of $0.01, the token has since surged to $0.035 in Phase 6, marking a 250% ...

Sarepta Therapeutics said it received approval from the Food & Drug Administration to update prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy.

The jobs report for September will be released on Thursday, the Bureau of Labor Statistics announced, giving markets one more piece of the economic puzzle to digest. Delayed by the government shutdown ...